Introduction {#s0005}
============

Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes and is the leading cause of end-stage renal disease (ESRD) globally ([@bb0040], [@bb0105]). It has become the primary diagnosis in almost 50% of patients starting renal replacement therapy in some Asian countries ([@bb0180]), in Europe and in the US. Asians, including Chinese type 2 diabetic subjects, have a higher prevalence of nephropathy, with 20% having clinical proteinuria and 40% microalbuminuria ([@bb0200]).

Why some type 2 diabetics develop nephropathy, whereas others do not, despite having a long-term hyperglycemia remains unknown. Accumulated evidences suggest that both environmental and genetic factors are related with the etiology of DN ([@bb0005], [@bb0125], [@bb0170]). A number of genes have been suggested as diabetic nephropathy candidate genes, for example, angiotensin-converting enzyme (ACE) ([@bb0195]), eNOS, methylenetetrahydrofolate reductase (MTHFR) ([@bb0210]), among which eNOS may play a critical role because endothelial dysfunction is considered as an important pathophysiologic factor for DN ([@bb0075]).

Nitric oxide (NO), a vasodilator molecule, is produced through the oxidation of [l]{.smallcaps}-arginine by eNOS ([@bb0130]). NO can regulate endothelial function and is an important factor in the maintenance of homeostasis. The presence of eNOS polymorphisms might contribute to a decreased eNOS activity and a reduced NO level, and has been reported to be a potential factor in the pathogenesis and development of DN ([@bb0010], [@bb0150]). This polymorphism consists of the two alleles of eNOS 4a with 4 tandem 27-repeats and eNOS 4b with 5 repeats ([@bb0025]).

To date, many studies have been carried out to investigate the relationship between eNOS-4b/a polymorphism and the risk of DN among type 2 diabetic subjects, but results of these studies were conflicting and inconclusive. Some studies observed that there was an association between eNOS-4b/a polymorphism and the risk of DN in patients with type 2 diabetes ([@bb0010]); while others suggested that there was no significant association ([@bb0070], [@bb0165]). To draw a more reliable conclusion, we performed a meta-analysis of all available studies dealing with the relationship between the eNOS-4b/a polymorphism and DN among type 2 diabetic subjects. Subgroup analyses were performed according to different geographic location to investigate ethnicity-specific effects.

Materials and methods {#s0010}
=====================

Literature search strategy {#s0015}
--------------------------

Two investigators (ZJM and HZR) independently searched Pubmed, Embase, the China National Knowledge Infrastructure (CNKI) database and the Wanfang Database. The last updated search was performed on May 26th, 2013. We used any possible combinations of relevant keywords of "Endothelial nitric oxide synthase", "eNOS", "4b/a", "polymorphism" and each term designating "T2DM-DN" (e.g., "type 2 diabetes", "T2D", "nephropathy", "albuminuria", "proteinuria", and "ESRD"). We also reviewed all the references cited in these articles to identify additional relevant publications. There was no language limitation. For overlapping publications, only the most recent or complete study was included in this meta-analysis.

Inclusion and exclusion criteria {#s0020}
--------------------------------

All studies included in the meta-analysis were required to meet the following criteria: (1) case--control, (2) studies investigating the association of eNOS-4b/a polymorphism with T2DM-DN as the outcome, (3) the control group with subjects who had T2DM but were free of diabetic kidney disease, (4) available data to estimate an odds ratio (OR) with 95% confidence interval (CI),and (5) genotype distribution among the control group must be in Hardy--Weinberg equilibrium (HWE).

Studies were excluded if one of the following existed: (1) review articles and editorials; (2) case reports; (3) repeat or overlapping publications; (4) no report about the genotype frequency, or insufficient information for data extraction.

Data extraction {#s0025}
---------------

Two investigators (ZJM and HZR) collected the data independently from all eligible publications. Disagreements about eligibility were resolved during a consensus with a third reviewer (RC) until consensus was achieved on every item. The following data were extracted from each study: name of the first author, year of publication, country of the study, ethnicity, number of cases and controls, genotype and allele frequencies, and genotyping method. Populations were categorized into Asian and non-Asian.

Statistical analysis {#s0030}
--------------------

The strength of relationship between eNOS-4b/a polymorphism and DN risk was expressed with OR and corresponding 95% CIs. The association was evaluated with the use of the allelic model (a vs b), as well as the additive model (aa vs. bb), the dominant model (aa + ab vs bb) and the recessive model (aa vs ab + bb). Heterogeneity was assessed using the Cochran Q chi-square test and the I^2^ test ([@bb0050]). A P value less than 0.10 indicated significant heterogeneity. We considered I^2^ values less than 25% to represent low heterogeneity, values between 25% and 50% to represent moderate heterogeneity, and values of 50% or greater to represent high heterogeneity. The fixed-effects model (FEM) was used when there was no heterogeneity among the included studies; otherwise, the random-effects model (REM) was used. In the subgroup analysis, statistical analysis was conducted according to different geographic location. Sensitivity analysis was performed to estimate the stability by omitting one study at a time to examine influence of one study on the overall summary estimate. Funnel plot and Egger\'s test were performed to assess publication bias ([@bb0020], [@bb0060]). An asymmetric plot or the P-value of Egger\'s test less than 0.1 suggested possible publication bias. Analyses were performed using the software Review Manage 5.2, publication bias was conducted using STATA software (version 12.0; Stata, College Station, TX). A two-sided P \< 0.05 was considered statistically significant.

Results {#s0035}
=======

Characteristics of the studies {#s0040}
------------------------------

A total of 59 articles were identified. The flow chart of study selection is shown in [Fig. 1](#f0005){ref-type="fig"}. Of these, 41 were excluded because they did not meet the criteria or were over-lapping publications. Finally, a total of 18 studies published between 2000 and 2013 were identified according to our inclusion criteria, involving 2972 cases and 2700 controls. The sample size in these case--control studies varied considerably (range from 84 to 903 individuals). All of the included studies used polymerase chain reaction (PCR) or PCR-restriction fragment length polymorphism (PCR-RFLP) to check genotypes. The main study characteristics were listed in [Table 1](#t0005){ref-type="table"}. The genotype and allele distributions for each study and HWE in controls were summarized in [Table 2](#t0010){ref-type="table"}. Of the 18 studies, three were non-Asian population ([@bb0045], [@bb0065], [@bb0165]), 15 studies were Asian population, including eight studies conducted in the Chinese population ([@bb0055], [@bb0080], [@bb0095], [@bb0110], [@bb0120], [@bb0175], [@bb0205], [@bb0215]) and seven studies conducted in the non-Chinese population ([@bb0010], [@bb0030], [@bb0070], [@bb0145], [@bb0155], [@bb0160], [@bb0185]).

Overall meta-analysis and subgroup analyses {#s0045}
-------------------------------------------

The summary of the meta-analysis for eNOS-4b/a gene polymorphisms and DN was shown in [Table 3](#t0015){ref-type="table"}. Significant association was found between the 4a allele and increased risk of DN when compared with the 4b allele in overall populations (REM OR = 1.44, 95% CI = 1.14--1.82) ([Fig. 2](#f0010){ref-type="fig"}). Significant associations were also found under additive model (REM OR = 2.03, 95% CI = 1.14--3.62) ([Fig. 3](#f0015){ref-type="fig"}), dominant model (REM OR = 1.34, 95% CI = 1.07--1.68) ([Fig. 4](#f0020){ref-type="fig"}) and recessive model (REM OR = 2.01, 95% CI = 1.12--3.61) ([Fig. 5](#f0025){ref-type="fig"}).

Sub-group analysis was performed according to different geographic location (Asian and non-Asian) in this meta-analysis. For Asian population, the 4a allele was found contributing significantly to increased DN risk in allelic model (REM: OR = 1.59, 95% CI = 1.22--2.09), additive model (FEM: OR = 3.94, 95% CI = 2.72--5.71), dominant model (REM: OR = 1.48, 95% CI = 1.12--1.95), and recessive model (FEM: OR = 4.01, 95% CI = 2.78--5.80), respectively. No significant association was found in any of the above mentioned models for non-Asian population (data were shown in [Table 3](#t0015){ref-type="table"}).

Sub-group analysis according to different country (Chinese population and non Chinese population) in Asian populations was also performed in this meta-analysis. Of all, eight case--control studies with 906 cases and 685 controls were conducted in the Chinese population, seven case--control studies with 1164 cases and 1200 controls were examined in the non-Chinese population. Significant associations were found under allelic model (REM: OR = 2.02, 95% CI = 1.31--3.11), recessive (FEM: OR = 2.25, 95% CI = 1.22--4.13), dominant (REM: OR = 2.05, 95% CI = 1.25--3.36) and additive (FEM: OR = 2.25, 95% CI = 1.22--4.13) models among the Chinese population. For non-Chinese population, significant associations were found under recessive (FEM: OR = 5.52, 95% CI = 3.43--8.89) and additive (FEM: OR = 5.31, 95% CI = 3.29--8.56) models, but the association was not found in allelic model (REM: OR = 1.34, 95% CI = 0.98--1.83) and dominant model (FEM: OR = 1.20, 95% CI = 0.99--1.45).

Publication bias diagnostics {#s0050}
----------------------------

Begg\'s funnel plot and Egger\'s test were performed to evaluate the publication bias in this meta-analysis. The shapes of the funnel plots in all genetic models did not reveal any sign of obvious asymmetry (Figure not shown). The Egger\'s test showed that there was no significant publication bias for any of the four genetic models (for a versus b: P = 0.837; for aa versus bb: P = 0.387; for aa + ab versus bb: P = 0.902; for aa versus ab + bb: P = 0.434).

Sensitivity analysis {#s0055}
--------------------

Sensitivity analysis was performed by sequentially excluding one study at a time. The results indicated that fixed-effects estimates and/or random-effects estimates before and after sequential omission of each study were similar at large (data not shown), which suggested that the results of this meta-analysis were reliable and robust.

Discussion {#s0060}
==========

DN is the major cause of end-stage renal disease globally and is the second cause of blood dialysis in China (13.5%) ([@bb0115]). The etiology of DN is multi-factorial and involves both environmental and genetic factors. It is still a major challenge for clinicians and researchers to elucidate the pathogenesis of DN and identify patients at DN risk. Genetic studies may provide valuable information with regard to the pathobiology of DN, and in the recent years, interest in the genetic susceptibility to DN has evoked a growing attention to the investigation of susceptibility polymorphisms of DN ([@bb0085], [@bb0190]).

Vascular endothelial dysfunction is prevalent in diabetes and has been shown to be an important pathophysiologic factor for DN ([@bb0035]). eNOS plays a critical role in the regulation of endothelial function through production of NO ([@bb0135]). The mechanism responsible for the potential association between eNOS polymorphisms and risk of DN is still unclear. However, eNOS activity and NO levels have been suggested as one of the critical factor for whether patients with diabetes are at risk for developing DN. Increased availability of eNOS may be an effective strategy in restoring endothelial function in patients with diabetic nephropathy ([@bb0015]). Polymorphisms in the eNOS gene may lead to defective NO synthesis and decreased NO levels, contribute to the development and progression of DN ([@bb0010], [@bb0150]). Therefore, this metabolic pathway of diabetes may be associated with renal complications of diabetes.

In the past two decades, a number of case--control studies were performed to evaluate the association between eNOS-4b/a polymorphism and risk of DN in type 2 diabetes patients, but because of relatively small sample size and the low statistical power of individual studies, results remained inconclusive. A meta-analysis was published in 2009 to assess the association between eNOS-4b/a polymorphisms and risk of DN in type 2 diabetes patients ([@bb0220]). However, the meta-analysis didn\'t report an obvious association between eNOS-4b/a polymorphisms and risk of DN in type 2 diabetes patients. From 2009, several new studies have been performed to further investigate this association, but the association between the eNOS-4b/a polymorphisms and risk of DN is still unclear. To obtain a more reliable conclusion, we conducted the present meta-analysis of all available studies based on 18 studies published from 2000 to 2013, involving 2972 cases and 2700 controls. Significant association was found between the 4a allele and increased risk of DN when compared with the 4b allele in all populations from the present meta-analysis. According to those results, we conclude that eNOS-4b/a would be considered as an effective genetic factor, which contributed to the pathology of DN in type 2 diabetes patients.

The geographic and ethnic differences might be an important factor to effect the association of gene polymorphism with the susceptibility of DN in type 2 diabetes patients. The results of subgroup analyses indicated that significant association of eNOS-4b/a polymorphism with DN only existed in Asian population, but not in non-Asian population. Furthermore, such association appeared to be enhanced when subgroup studies were performed among Chinese population. The differences in ethnic backgrounds, lifestyle or public sanitation may partly explain this discrepancy ([@bb0090], [@bb0100]). Further ethnic-specific association studies should be performed to investigate the population discrepancy of DN susceptibility.

Heterogeneity is one of the important issues when interpreting the results of meta-analysis ([@bb0140]). Our results indicated that heterogeneity existed in the overall analysis. After subgroup analysis by ethnicity and country, the heterogeneity was decreased or removed, suggesting that certain effects of genetic variants are ethnic specific. Publication bias is an important factor to affect us to get a reliable conclusion for meta-analysis. In this meta-analysis, no significant publication bias for 4b/a polymorphism in any of the above-mentioned inherited models was found, suggesting the associations observed should be stable. Sensitivity analyses did not significantly alter the results, also suggesting that the association was reliable and stable.

Despite our efforts in performing a comprehensive analysis, several limitations exist in this meta-analysis. First, only published studies in English or Chinese were included for data analysis, some potential studies with other languages or unpublished could be missed. Second, the majority of studies involved Asian populations, whereas non-Asian populations were only seen in three studies, more studies needed to be performed to investigate the association in non-Asian populations. Third, the ORs obtained by all comparison models were unadjusted, and a more precise analysis should be conducted if all individual raw data were available. This would allow for adjustment by other covariates such as age, gender, glycemic control, hypertension, smoking status, family history, lifestyle, environmental factors, and so on. Fourth, genotyping methods were different among the selected studies, which might affect the results. Finally, DN is a complex disease, and many genes are related to DN, however, we could not address gene--gene interactions in our study due to the lack of the related information. Despite these limitations, our study provided a better understanding of the association between eNOS-4b/a gene polymorphisms and risk of DN in type 2 diabetes.

In conclusion, our meta-analysis supported an association between the 4b/a polymorphism of eNOS gene and increased risk of DN in type 2 diabetes. However, significant association only existed in Asian populations, especially in Chinese population. As for non-Asian populations, no significant association was found under all the genetic models. Taking into account the limitations of this meta-analysis, further larger well-designed studies involving different ethnic populations, particularly referring to gene--gene and gene--environment interactions are required to warrant and validate our findings.
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###### 

Main characteristics of included studies in the meta-analysis.

  Author              Year   Country   Ethnicity     Case/control   Genotyping methods
  ------------------- ------ --------- ------------- -------------- --------------------
  Ahluwalia et al.    2008   India     South-Asian   195/255        PCR-RFLP
  Cheema et al.       2013   India     South-Asian   320/490        PCR-RFLP
  Degen et al.        2001   Germany   Caucasian     197/217        PCR
  Dong et al.         2005   China     East-Asian    70/64          PCR
  Ezzidi et al.       2008   Tunisia   Arabs         505/398        PCR-RFLP
  Fujita et al.       2000   Japan     East-Asian    86/69          PCR
  Guo et al.          2011   China     East-Asian    69/73          PCR-RFLP
  Huang et al.        2003   China     East-Asian    141/61         PCR
  Lin et al.          2002   China     East-Asian    79/48          PCR
  Luo et al.          2003   China     East-Asian    49/35          PCR
  Neugebauer et al.   2000   Japan     East-Asian    133/82         PCR
  Rahimi et al.       2013   Iran      West-Asian    121/52         PCR-RFLP
  Shimizu et al.      2002   Japan     East-Asian    230/203        PCR
  Shoukry et al.      2012   Egypt     Arabs         200/200        PCR-RFLP
  Sun et al.          2004   China     East-Asian    188/114        PCR
  Taniwaki et al.     2001   Japan     East-Asian    79/48          PCR
  Xing et al.         2004   China     East-Asian    130/136        PCR
  Zhang et al.        2005   China     East-Asian    180/154        PCR

###### 

The distribution of the 4b/a genotype and allele frequency for cases and controls.

                      Distribution of 4b/a eNOS genotype   Allele frequency                                                  
  ------------------- ------------------------------------ ------------------ ----- ---- ----- ----- ----- ----- ----- ----- -----
  Ahluwalia et al.    21                                   28                 146   5    61    189   70    320   71    439   Yes
  Cheema et al.       51                                   61                 208   10   118   363   163   477   138   844   Yes
  Degen et al.        2                                    53                 142   6    50    161   57    337   62    372   Yes
  Dong et al.         0                                    27                 43    0    11    53    27    113   11    117   Yes
  Ezzidi et al.       29                                   162                314   21   143   234   220   790   185   611   Yes
  Fujita et al.       2                                    21                 63    0    19    50    25    147   19    119   Yes
  Guo et al.          6                                    7                  56    3    0     70    19    119   6     140   Yes
  Huang et al.        2                                    31                 108   0    8     53    35    247   8     114   Yes
  Lin et al.          0                                    8                  71    1    6     41    8     150   8     88    Yes
  Luo et al.          27                                   2                  20    8    4     23    56    42    20    50    Yes
  Neugebauer et al.   6                                    26                 101   1    10    71    38    228   12    152   Yes
  Rahimi et al.       3                                    32                 86    0    14    38    38    204   14    90    Yes
  Shimizu et al.      6                                    44                 180   3    44    156   56    404   50    356   Yes
  Shoukry et al.      12                                   64                 124   9    60    131   88    312   78    322   Yes
  Sun et al.          4                                    48                 136   2    11    101   56    320   15    213   Yes
  Taniwaki et al.     0                                    8                  71    1    6     41    8     150   8     88    Yes
  Xing et al.         4                                    16                 110   0    8     128   24    236   8     264   Yes
  Zhang et al.        0                                    21                 159   2    21    131   21    339   25    283   Yes

HWE: Hardy--Weinberg equilibrium.

###### 

Meta analysis of the association of eNOS-4b/a gene polymorphism with DN in type 2 diabetes.

  Genetic model       Populations   Studies   Number of   Heterogeneity   I^2^ (%)   OR (95% CI)               P value
  ------------------- ------------- --------- ----------- --------------- ---------- ------------------------- ------------
  a versus b          All           18        2972/2700   \< 0.00001      74         1.44 (1.14--1.82) (REM)   0.0002
                      Non-Asian     3         902/815     0.52            0          0.99 (0.84--1.17) (FEM)   0.92
                      Asian         15        2070/1885   0 \< 0.0001     67         1.59 (1.22--2.09) (REM)   0.0007
                      China         8         906/685     0.001           70         2.02 (1.31--3.11) (REM)   0.006
                      Non-China     7         1164/1200   0.01            64         1.34 (0.98--1.83) (REM)   0.07
  aa versus bb        All           18        2972/2700   0.0006          61         2.03 (1.14--3.62) (REM)   0.02
                      Non-Asian     3         902/815     0.38            0          1.02 (0.64--1.61) (FEM)   0.95
                      Asian         15        2070/1885   0.10            35         3.94 (2.72--5.71) (FEM)   \< 0.00001
                      China         8         906/685     0.28            20         2.25 (1.22--4.13) (FEM)   0.009
                      Non-China     7         1164/1200   0.18            32         5.31 (3.29--8.56) (FEM)   \< 0.00001
  aa + ab versus bb   All           18        2972/2700   0.0004          61         1.34 (1.07--1.68) (REM)   0.010
                      Non-Asian     3         902/815     0.41            0          0.98 (0.80--1.20) (FEM)   0.85
                      Asian         15        2070/1885   0.002           60         1.48 (1.12--1.95) (REM)   0.006
                      China         8         906/685     0.008           63         2.05 (1.25--3.36) (REM)   0.005
                      Non-China     7         1164/1200   0.22            27         1.20 (0.99--1.45) (FEM)   0.06
  aa versus bb + ab   All           18        2972/2700   0.0004          62         2.01 (1.12--3.61) (REM)   0.02
                      Non-Asian     3         902/815     0.36            1          1.04 (0.66--1.64) (FEM)   0.87
                      Asian         15        2070/1885   0.07            39         4.01 (2.78--5.80) (FEM)   \< 0.00001
                      China         8         906/685     0.24            24         2.21 (1.21--4.05) (FEM)   0.010
                      Non-China     7         1164/1200   0.18            33         5.52 (3.43--8.89) (FEM)   \< 0.00001

OR, odds ratio; CI, confidence interval.
